A novel biomarker for gut leakage as a diagnostic tool for HIV disease progression

Investigating a novel plasma biomarker's potential for identifying gut leakage.

A novel gel for targeting vaginal inflammation to prevent HIV transmission

Developing an intravaginal gel delivering a vaginal microbiota metabolite.

Accelerating ART initiation among Infants (AAMI Study)

This project will trial the POC VISITECT® CD4 test and POC LYNX HIV p24 early infant diagnostic test.

Access to affordable and accurate HIV-1 VL testing

Laboratory evaluation of a novel filter paper-based method of plasma separation for viral load testing.

Access to CD4 (VISITECT® CD4) testing among HIV-infected women in Kenya

An accessible CD4 (VISITECT® CD4) test for HIV-infected pregnant and postpartum women in Kenya.

ACCESS: STI and BBV surveillance system

ACCESS is a surveillance system that collates important information on a range of STIs and BBVs.

Antibody mAbs to destroy infection: engineering the next generation treatments

Applying discoveries from our cancer mAb program to neutralize and destroy pathogens.

Antimicrobial and immune modulatory effects of vaginal microbiota metabolites

Determining the role of vaginal microbiota metabolites in inactivating HIV and other STIs, and their immune modulatory effects on cells found in the lower female reproductive tract .

Broadly neutralising anti-HIV antibodies and Fc Receptor function

Defining the properties of anti-HIV antibodies for vaccine development and protection of pregnant women.

co-EC Study: Eliminating hepatitis C/HIV coinfection

Eliminating hepatitis C transmission by enhancing care and treatment among HIV co-infected individuals.

Community-Based Rapid HIV Testing Services

Evaluating a multi-site rapid HIV testing trial in South Australia and rural site in Bendigo, Victoria.

DARE C: ATAHC II Substudy

DARE-C aims to evaluate therapy duration using triple therapy (PEG-IFN/RBV/TPV).

Decision science using Optima

Research and applications across disease areas to improve allocative efficiency.

Developing new HIV disease progression tests

This project will develop prognostic tools to identify HIV+ persons at risk of rapid disease progression.

Development of a novel prophylactic vaccine candidate for HIV-1

A prophylactic vaccine represents the best strategy for blocking HIV-1 transmission.

Development of hydrogel based intravaginal drug delivery device

Developing an intravaginal ring to deliver a microbiota metabolite.

Harm reduction among People who Inject Drugs in Myanmar

Aims to prevent the transmission of HIV among young people, students, migrant and transport workers.

HIV Prevention Cohort

Online cohort study of gay men in Victoria monitoring community-level change.

HIV testing among young men who have sex with men in Myanmar

Examining factors associated with HIV testing uptake among young men who have sex with men in Myanmar.

Impact of a vaginal microbiota metabolite on epithelium integrity and HIV susceptibility

Determining the role of a vaginal microbiota metabolite in enhancing the mucosal barrier to prevent HIV transmission.

Mechanism of action of dendrimer microbicides against HIV

This study will lead to a greater understanding of how dendrimer nanoparticles can block HIV infection.

Plasma separator device for HIV viral load testing

Aimed at improving access to HIV viral load assays in resource-limited settings.

Predicting quality and potency of monoclonal and natural antibodies

Rapid, simple and scalable assays for predicting antibody potency.

PrEPX: Rapid scale-up of HIV pre-exposure prophylaxis (PrEP)

Burnet is playing a crucial role in monitoring the outcomes of the PrEPX trial in Victoria.

PRONTO! Rapid HIV point-of-care testing in Victoria

The first rapid HIV test service in Victoria targeting gay men and men who have sex with men.

Sexual Health And Risk Prevention (SHARP) Study

Assessing responses to HIV prevention measures among Australian MSM.

TAIPAN: HIV cascade surveillance

Internationally novel project to create a linked surveillance system to monitor the HIV cascade for gay men

Targeting novel sites on reverse transcriptase for HIV treatment and prevention

Discovering a new HIV drug class.

The Victorian Primary Care Network for Sentinel Surveillance on BBVs and STIs

The surveillance involves collection and linking of testing, demographic, and risk behaviour information.

Transmitted and acquired drug resistant HIV strains in Victoria, Australia

Documenting mutations associated with drug resistance acquired by patients diagnosed with HIV.

VISITECT® CD4 point-of-care test

An affordable HIV point-of-care test developed by Burnet but licensed to Omega Diagnostics.